Mark Bycroft
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark Bycroft has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Mark D. Allen
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK
3 shared publicationsAlan J. Warren
‡Medical Research Council Centre for Protein Engineering and §Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH and the ¶Department of Haematology, University of Cambridge, Hills Road, Cambridge CB2 2XY, United Kingdom
1 shared publication- Andreas Christian Joerger
Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt am Main, Germany
1 shared publication Charles G. Grummitt
Medical Research Council Centre for Protein Engineering, Cambridge CB2 0QH, UK
1 shared publicationChristopher M. Johnson
‡Medical Research Council Centre for Protein Engineering and §Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH and the ¶Department of Haematology, University of Cambridge, Hills Road, Cambridge CB2 2XY, United Kingdom
1 shared publicationFiona M. Townsley
‡Medical Research Council Centre for Protein Engineering and §Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH and the ¶Department of Haematology, University of Cambridge, Hills Road, Cambridge CB2 2XY, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 23 May 2016
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 72 (6) , 500-506
High-resolution NMR structures of the domains ofSaccharomyces cerevisiaeTho1
THO is a multi-protein complex involved in the formation of messenger ribonuclear particles (mRNPs) by coupling transcription with mRNA processing and export. THO is thought to be formed from five subunits, Tho2p, Hpr1p, Tex1p, Mft1p and Thp2p, and recent work has determined a low-resolution structure of the complex [Poulsenet al.(2014),PLoS One,9, e103470]. A number of additional proteins are thought to be involved in the formation of mRNP in yeast, including Tho1, which has been shown to bind RNAin vitroand is recruited to actively transcribed chromatinin vivoin a THO-complex and RNA-dependent manner. Tho1 is known to contain a SAP domain at the N-terminus, but the ability to suppress the expression defects of thehpr1Δ mutant of THO was shown to reside in the RNA-binding C-terminal region. In this study, high-resolution structures of both the N-terminal DNA-binding SAP domain and C-terminal RNA-binding domain have been determined.
- 23 May 2016
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 72 (6) , 500-506
Open AccessHigh-resolution NMR structures of the domains ofSaccharomyces cerevisiaeTho1
THO is a multi-protein complex involved in the formation of messenger ribonuclear particles (mRNPs) by coupling transcription with mRNA processing and export. THO is thought to be formed from five subunits, Tho2p, Hpr1p, Tex1p, Mft1p and Thp2p, and recent work has determined a low-resolution structure of the complex [Poulsenet al.(2014),PLoS One,9, e103470]. A number of additional proteins are thought to be involved in the formation of mRNP in yeast, including Tho1, which has been shown to bind RNAin vitroand is recruited to actively transcribed chromatinin vivoin a THO-complex and RNA-dependent manner. Tho1 is known to contain a SAP domain at the N-terminus, but the ability to suppress the expression defects of thehpr1Δ mutant of THO was shown to reside in the RNA-binding C-terminal region. In this study, high-resolution structures of both the N-terminal DNA-binding SAP domain and C-terminal RNA-binding domain have been determined.
- Open Access
- 2 July 2014
- Published by Wiley in Protein Science
- Vol. 23 (9) , 1301-1308
A high‐resolution structure of the EF‐hand domain of human polycystin‐2
Autosomal dominant polycystic kidney disease (ADPKD) affects over 1:1000 of the worldwide population and is caused by mutations in two genes, PKD1 and PKD2. PKD2 encodes a 968‐amino acid membrane spanning protein, Polycystin‐2 (PC‐2), which is a member of the TRP ion channel family. The C‐terminal cytoplasmic tail contains an EF‐hand motif followed by a short coiled‐coil domain. We have determined the structure of the EF‐hand region of PC‐2 using NMR spectroscopy. The use of different boundaries, compared with those used in previous studies, have enabled us to determine a high resolution structure and show that the EF hand motif forms a standard calcium‐binding pocket. The affinity of this pocket for calcium has been measured and mutants that both decrease and increase its affinity for the metal ion have been created.
- 2 July 2014
- Published by Wiley in Protein Science
- Vol. 23 (9) , 1301-1308
Open AccessA high‐resolution structure of the EF‐hand domain of human polycystin‐2
Autosomal dominant polycystic kidney disease (ADPKD) affects over 1:1000 of the worldwide population and is caused by mutations in two genes, PKD1 and PKD2. PKD2 encodes a 968‐amino acid membrane spanning protein, Polycystin‐2 (PC‐2), which is a member of the TRP ion channel family. The C‐terminal cytoplasmic tail contains an EF‐hand motif followed by a short coiled‐coil domain. We have determined the structure of the EF‐hand region of PC‐2 using NMR spectroscopy. The use of different boundaries, compared with those used in previous studies, have enabled us to determine a high resolution structure and show that the EF hand motif forms a standard calcium‐binding pocket. The affinity of this pocket for calcium has been measured and mutants that both decrease and increase its affinity for the metal ion have been created.
- 24 October 2011
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 21 (6) , 761-766
Recognition of non-methyl histone marks
- 24 October 2011
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 21 (6) , 761-766
Recognition of non-methyl histone marks
- Open Access
- 23 June 2010
- Published by Wiley in Protein Science
- Vol. 19 (7) , 1432-1438
The structure of the FYR domain of transforming growth factor beta regulator 1
Many chromatin‐associated proteins contain two sequence motifs rich in phenylalanine/tyrosine residues of unknown function. These so‐called FYRN and FYRC motifs are also found in transforming growth factor beta regulator 1 (TBRG1)/nuclear interactor of ARF and MDM2 (NIAM), a growth inhibitory protein that also plays a role in maintaining chromosomal stability. We have solved the structure of a fragment of TBRG1, which encompasses both of these motifs. The FYRN and FYRC regions each form part of a single folded module (the FYR domain), which adopts a novel α + β fold. Proteins such as the histone H3K4 methyltransferases trithorax and mixed lineage leukemia (MLL), in which the FYRN and FYRC regions are separated by hundreds of amino acids, are expected to contain FYR domains with a large insertion between two of the strands of the β‐sheet.
- 23 June 2010
- Published by Wiley in Protein Science
- Vol. 19 (7) , 1432-1438
Open AccessThe structure of the FYR domain of transforming growth factor beta regulator 1
Many chromatin‐associated proteins contain two sequence motifs rich in phenylalanine/tyrosine residues of unknown function. These so‐called FYRN and FYRC motifs are also found in transforming growth factor beta regulator 1 (TBRG1)/nuclear interactor of ARF and MDM2 (NIAM), a growth inhibitory protein that also plays a role in maintaining chromosomal stability. We have solved the structure of a fragment of TBRG1, which encompasses both of these motifs. The FYRN and FYRC regions each form part of a single folded module (the FYR domain), which adopts a novel α + β fold. Proteins such as the histone H3K4 methyltransferases trithorax and mixed lineage leukemia (MLL), in which the FYRN and FYRC regions are separated by hundreds of amino acids, are expected to contain FYR domains with a large insertion between two of the strands of the β‐sheet.
- Open Access
- 1 August 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (34) , 23326-23332
Structural Consequences of Nucleophosmin Mutations in Acute Myeloid Leukemia
- 1 August 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (34) , 23326-23332
Open AccessStructural Consequences of Nucleophosmin Mutations in Acute Myeloid Leukemia